HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement Industry Strongly Contributes To Economic Health – Report

This article was originally published in The Tan Sheet

Executive Summary

The dietary supplement industry is directly and indirectly responsible for about $61 billion in annual expenditures and more than 450,000 jobs, according to a report on the industry's impact on the U.S. economy

You may also be interested in...



Health Care Savings From Lutein, Zeaxanthin Becoming Clear – Study

Daily intake of 6 to 10 mg of lutein with zeaxanthin by people at risk for age-related macular degeneration could generate $3.6 billion in net health care savings over a five-year period, according to an economic analysis

Grassley’s Swing At Illegal Anabolic Steroid Use Unfairly Strikes DHEA – CRN

Legislation introduced in response to a report on steroid use in Major League Baseball that would put an age restriction on sales of performance-enhancing drugs and supplements - including DHEA - is a "misdirected attempt ... based on emotional rhetoric" to curb illegal anabolic steroid use, industry leaders say

NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building

NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS136299

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel